Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 13/20 | 0.56 |
| ▸ | ITGA4 | P13612 | 13/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.48 |
| ▸ | F2 | P00734 | 2/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | CCKAR | P32238 | 1/20 | 0.42 |
| ▸ | CCKBR | P32239 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21635820 | 0.94 | ITGB1 (0.55) | ITGB1ITGA4F2ACE | |
| SCHEMBL21635751 | 0.92 | ITGB1 (0.52) | ITGB1ITGA4 | |
| SCHEMBL21635821 | 0.87 | ITGB1 (0.51) | ITGB1ITGA4 | |
| SCHEMBL21635799 | 0.82 | ITGB1 (0.48) | ITGB1ITGA4 | |
| SCHEMBL21635810 | 0.81 | ITGB1 (0.48) | ITGB1ITGA4 | |
| SCHEMBL21635823 | 0.81 | ITGB1 (0.47) | ITGB1ITGA4 | |
| SCHEMBL24117499 | 0.80 | ITGB1 (0.47) | ITGB1ITGA4 | |
| SCHEMBL21635763 | 0.80 | ITGB1 (0.56) | ITGB1ITGA4F2 | |
| SCHEMBL21635796 | 0.79 | ITGB1 (0.55) | ITGB1ITGA4 | |
| SCHEMBL21635787 | 0.77 | ITGB1 (0.49) | ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395302-A1 | PEPTIDES FOR ACTIVATION OF CELL SIGNALING IN OSTEOPROGENITOR CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-12-23 | — | — | US | disclosed |
| WO-2020018941-A1 | PEPTIDES FOR ACTIVATION OF CELL SIGNALING IN OSTEOPROGENITOR CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395302-A1 | PEPTIDES FOR ACTIVATION OF CELL SIGNALING IN OSTEOPROGENITOR CELLS | ITGB4, ITGA4, ITGB1 | ITGB1 3/4885ITGA4 2/4885KISS1R 649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.